Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
China · Delayed Price · Currency is CNY 15.77
-0.42 (-2.59%)
Jun 2, 2026, 3:04 PM CST
Beijing Scitop Bio-tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 89.14 | 94.52 | 94.36 | 93.48 | 109.89 | 109.54 |
Depreciation & Amortization | 33.35 | 33.35 | 26.15 | 20.34 | 18.05 | 16.14 |
Other Amortization | 1 | 1 | 0.67 | 0.28 | 0.18 | 0.38 |
Loss (Gain) From Sale of Assets | - | - | -0.65 | -0.03 | 0.01 | -11.2 |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.31 | 0 | 0 | 0.15 |
Loss (Gain) From Sale of Investments | -3.8 | -3.8 | -5.59 | -7.38 | -9.34 | -13.16 |
Provision & Write-off of Bad Debts | 3.05 | 3.05 | -3.15 | 1.8 | 0.71 | 0.34 |
Other Operating Activities | -5.86 | -18.92 | -23.13 | -19.68 | -1.55 | -4.66 |
Change in Accounts Receivable | -26.42 | -26.42 | 21.01 | 39.22 | 9.27 | 19.96 |
Change in Inventory | -0.13 | -0.13 | -7.38 | 11.71 | 1.91 | -8.11 |
Change in Accounts Payable | 46.77 | 46.77 | 38.19 | -23.06 | 17.99 | -5.63 |
Change in Other Net Operating Assets | 1.27 | 1.27 | 1.74 | -7.35 | 1.5 | 7.79 |
Operating Cash Flow | 131.12 | 123.44 | 142.11 | 107.27 | 148.46 | 110.27 |
Operating Cash Flow Growth | 16.17% | -13.14% | 32.49% | -27.74% | 34.63% | 65.39% |
Capital Expenditures | -234.17 | -296.12 | -211.5 | -178.47 | -84.18 | -67.57 |
Sale of Property, Plant & Equipment | - | - | 0 | 0.05 | 0 | 9.58 |
Divestitures | - | - | - | - | - | 7.85 |
Investment in Securities | 145.13 | 207.16 | 27.16 | -561.29 | -288.86 | 302.71 |
Investing Cash Flow | -89.05 | -88.97 | -184.33 | -739.71 | -373.04 | 252.57 |
Long-Term Debt Repaid | - | -0.89 | -1.21 | -1.62 | -1.25 | -0.79 |
Total Debt Repaid | -0.89 | -0.89 | -1.21 | -1.62 | -1.25 | -0.79 |
Net Debt Issued (Repaid) | -0.89 | -0.89 | -1.21 | -1.62 | -1.25 | -0.79 |
Issuance of Common Stock | - | - | - | - | 693.83 | - |
Common Dividends Paid | -39.52 | -39.52 | -39.52 | -52.7 | -74.46 | -82.52 |
Financing Cash Flow | -40.41 | -40.41 | -40.73 | -54.32 | 618.12 | -83.31 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | - | - | - |
Net Cash Flow | 1.66 | -5.94 | -82.95 | -686.76 | 393.54 | 279.53 |
Free Cash Flow | -103.05 | -172.68 | -69.38 | -71.21 | 64.28 | 42.7 |
Free Cash Flow Growth | - | - | - | - | 50.55% | -5.94% |
Free Cash Flow Margin | -27.61% | -47.19% | -22.91% | -23.80% | 17.41% | 11.71% |
Free Cash Flow Per Share | -0.39 | -0.66 | -0.27 | -0.27 | 0.29 | 0.19 |
Cash Income Tax Paid | 24.45 | 21.85 | 25.73 | 45.64 | 30.19 | 36.49 |
Levered Free Cash Flow | 413.06 | -210.3 | -96.47 | -107.7 | 34.69 | 5.23 |
Unlevered Free Cash Flow | 413.1 | -210.21 | -96.32 | -107.39 | 34.94 | 5.5 |
Change in Working Capital | 14.22 | 14.22 | 53.15 | 18.47 | 30.51 | 12.74 |